首页 | 本学科首页   官方微博 | 高级检索  
检索        

长春瑞滨联合异环磷酰胺治疗非小细胞肺癌的疗效观察
引用本文:张丽琴,谢家政.长春瑞滨联合异环磷酰胺治疗非小细胞肺癌的疗效观察[J].临床肿瘤学杂志,2002,7(5):374-375.
作者姓名:张丽琴  谢家政
作者单位:241000,安徽芜湖,皖南医学院附属弋矶山医院呼吸内科
摘    要:目的 :观察长春瑞滨 (NVB)和异环磷酰胺 (IFO)联合治疗非小细胞肺癌 (NSCLC)的疗效和毒性。方法 :对于符合化疗指征的 2 0例NSCLC ,临床予NVB联合IFO(NI方案 )化疗 ,至少两个疗程 ,疗效及毒性判断按照WHO标准。结果 :有效率为 (45 % ) ,其中CR(5 % ) ,PR(40 % )。在毒性方面表现不同程度的白细胞下降、血小板下降、恶心及呕吐等。结论 :NI方案对治疗非小细胞肺癌有较高疗效 ,有条件可作为一线方案应用

关 键 词:长春瑞滨  异环磷酰胺  联合化疗  非小细胞肺癌
文章编号:1009-0460(2002)05-0374-02
修稿时间:2002年1月14日

Clinical study of vinorelbine combined with ifosfamide in treatment of non small cell lung cancer
Zhang Liqin,Xie Jiazheng.Clinical study of vinorelbine combined with ifosfamide in treatment of non small cell lung cancer[J].Chinese Clinical Oncology,2002,7(5):374-375.
Authors:Zhang Liqin  Xie Jiazheng
Institution:Zhang Liqin,Xie Jiazheng. Department of Respiratory,Yijishan Hospital,Wuhu 241000
Abstract:Objective:To observe the activity and toxicity of vinorelbine(NVB) combined with ifosfamid (IFO) in treatment of non small cell lung cancer (NSCLC).Methods:Twenty cases of NSCLC were treated with combination chemotherapy consisting of NVB and IFO for at least two cycles. The therapeutic effects and toxicity were evaluated according to WHO criteria.Results:Total remission rate is 45%, the CR is 5%, the PR is 40%, the main side effcts were leukopenia in some extent and thrombocytopenia, in some cases, nausea and vomiting were observed.Conclusion:NI regimen is one of the most effective regiments for advanced lung cancer. This regimen may be used as the first selection for eligible patients.
Keywords:Vinorebine  Ifosfamide  Combination  Chemotherapy  Non  small cell lung cancer
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号